Medipharm Labs LABS.TO · CAD

Its shares trade on Toronto Stock Exchange under the ticker LABS.TO. It has been listed since 9 February 2018. In the fiscal year to 31 December 2025, it reported revenue of C$45.1m and a net loss of C$8.3m. At that date it held total assets of C$45.7m and shareholders' equity of C$35.8m.

MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company is headquartered in Barrie, Ontario. The company went IPO on 2018-02-09. The firm is focused on distillation and cannabinoid isolation and purification. The firm actively builds an inventory of specialized consumer products in anticipation of federal legalization of the adult-use market in Canada. Outside of the Canadian market, the Company develops MediPharm Labs Australia facility, which is a purpose-built and component of the Company’s international investments. The firm operates with a processing capacity of approximately 100,000 kilograms of dry cannabis flower and trim per year.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Chris TavesIndependent Chairman of the BoardC$28,536
• Mr. David PidduckChief Executive Officer, Director, since 2022C$989,929
• Mr. Greg HunterChief Financial OfficerC$548,393
• Mr. Emily JamesonDirector
• Mr. John MedlandDirector
• Mr. Keith StrachanDirector, since 2018C$480,850
• Mr. Christopher HalykIndependent DirectorC$39,607
• Ms. Shelley PottsIndependent DirectorC$30,723

Overall

23

Environment

5

Social

32

Governance

33

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.